
About Amin Lab and Metabolic Therapeutics
Rajesh Amin
My overall research interest is focused on developing novel therapeutics for neurodegenerative diseases and other metabolic-related diseases. To achieve this goal, my research focuses on target identification, in silico-based drug design and development, synthesis, and testing in vitro and in vivo. For example, we have recently had success in developing libraries of compounds for various nuclear receptors and applied them to improve behavioral deficits and synaptic plasticity in models of type 2 diabetes and Alzheimer’s disease.
More recent work has focused upon studying the dynamics of gut brain metabolites that alter synaptic plasticity. Lastly, my lab is entering a new area focused upon mitigating spine alteration in neurodegeneration by regulating the players in actin dynamics. These studies are diverse in mechanism however they are years’ worth of work and help define my labs past, present and future directions for the development of novel therapeutics for preventing the progression of mild cognitive impairment to late stage Alzheimer’s disease.
After undergoing rigorous postdoctoral training, at the Center of Integrative Medicine and Endocrine Research, a metabolic group resulting from the closure of Pfizer Ann Arbor, Michigan. I joined Auburn University as Assistant Professor, tenure track in 2010 and subsequently moved to Auburn, Alabama. I was promoted to Associate Professor with Tenure in 2016.
We currently have received NIH, AHA, as well as institutional awards, including the very prestigious Presidential Award Institutional Research (PAIR) from Auburn University.

Rajesh Amin, Professor, PhD.
Phone: 334-844-8295



Describe your image

Outside of the Lab
Meet the Lab
Meet the ones running experiments, analyzing data, and bringing life to the lab.










